Every product in our catalog is domestically produced, lot-documented, and held to exacting quality standards.
A 15-amino-acid partial sequence of body protection compound. Domestically synthesized under verified quality standards with full lot traceability.
Synergistic GHRH + GHS-R dual-peptide blend. USA-synthesized and combined under documented quality protocols with full lot documentation.
Synthetic Thymosin Beta-4 fragment. Produced under domestic quality protocols with full lot-level documentation and traceability.
Copper-binding tripeptide with documented biological activity in cellular research models. USA synthesized under tightly controlled conditions.
Mitochondria-derived peptide studied in metabolic and cellular energy regulation research contexts. Domestically produced, lot-verified.
Synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied in telomere biology, pineal gland regulation, and longevity research pathways.
Synthetic analogue of endogenous GHRH. Studied in GH axis and metabolic research models. Domestic production, lot-documented.
Selective GHS-R agonist pentapeptide. Studied in GH secretagogue and pulsatile growth hormone release research contexts.
Synthetic melanocortin receptor agonist. Studied in melanogenesis, appetite regulation, and sexual function research models.
Bremelanotide — melanocortin receptor agonist derived from MT-2. Studied in central nervous system and sexual arousal pathway research.
Small molecule ERRα agonist studied in metabolic endurance and mitochondrial biogenesis research pathways. Domestically sourced.
GLP-1 receptor agonist studied in glucose metabolism, appetite regulation, and cardiometabolic research models. USA synthesized.
Higher concentration offering of our GLP-1 receptor agonist. Same domestic sourcing, amino acid sequence verified, lot-documented.
Triple receptor agonist targeting GIP, GLP-1, and glucagon receptors. Studied in metabolic and body composition research models.
High-yield 30 mg offering of our triple-agonist peptide. Domestic production, full amino acid sequence verified, lot-documented.
Dual GIP/GLP-1 receptor agonist studied in insulin secretion, glucagon suppression, and body composition research models.
Nicotinamide adenine dinucleotide studied in cellular energy metabolism, DNA repair, and longevity research pathways.
ACTH-derived heptapeptide studied in neuroprotection, BDNF expression, and cognitive function research. Domestic synthesis.
Synthetic heptapeptide analogue of human tuftsin. Studied in anxiolytic, immune modulation, and memory enhancement research contexts.
Combined BPC-157 and TB-500 blend — two of the most studied connective tissue and recovery peptides, co-lyophilized in a single vial. USA produced, lot-documented.
Renewa's proprietary skin and cellular support blend. Lyophilized powder formulated domestically with purity >99% and full amino acid sequence verification.
GHRH analogue comprising the first 29 amino acids of endogenous growth hormone-releasing hormone. Studied in GH axis stimulation research. Domestically produced.
High-yield 20 mg offering of our GLP-1 receptor agonist. Same domestic sourcing and lot-level documentation as our 5 mg and 10 mg SKUs.
Dual GIP/GLP-1 receptor agonist — 20 mg offering. Studied in insulin secretion, glucagon suppression, and body composition research. Domestically synthesized.
High-yield 30 mg offering of our dual GIP/GLP-1 agonist. Full amino acid sequence verified, lot-documented, USA synthesized under tightly controlled conditions.
Create a free account to place orders, access lot documentation, and manage your Renewa Health account.
All products for research use only. Not for human or veterinary use.